Trademark: 97394409
Word
PRORELIX RESEARCH
Status Date
Tuesday, February 27, 2024
Filing Date
Wednesday, May 4, 2022
Published for Opposition
Tuesday, February 27, 2024
44 Pharmaceutical compounding services
42 Clinical research in the field of Pharma, Biotech, Biopharma, Medical devices, Nutraceutical and Herbal domain; Development of pharmaceutical preparations and medicines; Information technology consulting services; Pharmaceutical drug development services; Pharmaceutical research services; Research and development and consultation related thereto in the field of Pharma, Biotech, Biopharma, Medical devices, Nutraceutical and Herbal domain; Research and development in the field of Pharma, Biotech, Biopharma, Medical devices, Nutraceutical and Herbal domain; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of technology in the field of Pharma, Biotech, Biopharma, Medical devices, Nutraceutical and Herbal domain; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Basic and clinical research in the field of respiratory science and medicine; Biochemical research and development; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Consulting services in the field of pharmaceutical research; Consulting services in the field of pharmaceutical research and development; Consulting in the field of information technology; Laboratory research services relating to pharmaceuticals; Medical and scientific research, namely, conducting clinical trials for others; Outsource service provider in the field of information technology consulting; Outsource service providers in the field of information technology; Pharmaceutical research and development; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research and development; Scientific research in the nature of conducting clinical trials for others; Scientific research in the nature of conducting clinical trials for others in the field of Pharma, Biotech, Biopharma, Medical devices, Nutraceutical and Herbal domain; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
The mark consists of the word "ProRelix RESEARCH" wherein the word 'Pro' is written in white contained within two green overlapping squares and the word 'Relix' written in dark green color and 'RESEARCH' written in green color to the right of the squares. The grey background is not a feature of the mark.
The color(s) green, dark green, white and grey is/are claimed as a feature of the mark.
"PRO" AND "RESEARCH"
Feb 27, 2024
Published For Opposition
Feb 7, 2024
Notification Of Notice Of Publication E-Mailed
Feb 7, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 22, 2024
Approved For Pub - Principal Register
Dec 20, 2023
Teas/Email Correspondence Entered
Dec 20, 2023
Correspondence Received In Law Office
Dec 20, 2023
Assigned To Lie
Jul 25, 2023
Notice Of Revival - E-Mailed
Jul 25, 2023
Teas Response To Office Action Received
Jul 25, 2023
Petition To Revive-Granted
Jul 25, 2023
Teas Petition To Revive Received
Jun 28, 2023
Teas Change Of Correspondence Received
Jun 28, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 28, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 21, 2023
Withdrawal Of Attorney Granted
Jun 21, 2023
Teas Withdrawal Of Attorney Received
Jun 15, 2023
Abandonment Notice E-Mailed - Failure To Respond
Jun 15, 2023
Abandonment Notice Mailed - Failure To Respond
Jun 15, 2023
Abandonment - Failure To Respond Or Late Response
Feb 23, 2023
Notification Of Non-Final Action E-Mailed
Feb 23, 2023
Non-Final Action E-Mailed
Feb 23, 2023
Non-Final Action Written
Feb 22, 2023
Assigned To Examiner
May 10, 2022
Notice Of Design Search Code E-Mailed
May 9, 2022
New Application Office Supplied Data Entered
May 7, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
